Skip to site menu Skip to page content

Drug Labeling Specialist on New Pregnancy Labeling Rules

By Pharmaceutical Development Group
On 30 June, 2015, new pregnancy labeling rules for prescription drugs took effect, marking the demise of pregnancy categories (A, B, C, D, X), which have been in use since 1979. The new rule ushers in what is expected to be an era of unprecedented inclusion with regard to descriptive risk and benefit information. The US Food and Drug Administration (FDA) said: "a narrative structure for pregnancy labeling, rather than a category system, is best able to capture and convey the potential risks of drug exposure based on animal or human data, or both". Download this free whitepaper to find out more.
Enter your details below to view the free white paper

By downloading this whitepaper, you acknowledge that GlobalData may share your information with our white paper partners/sponsors who may contact you directly with information on their products and services.

Visit our Privacy Policy for more information about our services, how GlobalData may use, process and share your personal data, including information on your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Related Content